Literature DB >> 29932284

Diagnosis of Beckwith-Wiedemann syndrome in children presenting with Wilms tumor.

Suzanne P MacFarland1, Kelly A Duffy2, Tricia R Bhatti3, Rochelle Bagatell1,4, Naomi J Balamuth1,4, Garrett M Brodeur1,4, Arupa Ganguly5, Peter A Mattei6, Lea F Surrey3, Frank M Balis1,4, Jennifer M Kalish2,4,5.   

Abstract

Beckwith-Wiedemann syndrome (BWS) is a genetic syndrome associated with overgrowth and cancer predisposition, including predisposition to Wilms tumor (WT). Patients with BWS and BWS spectrum are screened from birth to age 7 years for BWS-associated cancers. However, in some cases a BWS-associated cancer may be the first recognized manifestation of the syndrome. We describe 12 patients diagnosed with BWS after presenting with a WT. We discuss the features of BWS in these patients and hypothesize that earlier detection of BWS by attention to its subtler manifestations could lead to earlier detection of children at risk for associated malignancies.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Beckwith-Wiedemann spectrum; Beckwith-Wiedemann syndrome; Wilms tumor; cancer predisposition; isolated hemihypertrophy; isolated lateralized overgrowth; tumor screening

Mesh:

Year:  2018        PMID: 29932284      PMCID: PMC6107414          DOI: 10.1002/pbc.27296

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  20 in total

1.  Screening Hepatoblastoma in Beckwith-Wiedemann Syndrome: A Complex Issue.

Authors:  Alessandro Mussa; Giovanni Battista Ferrero
Journal:  J Pediatr Hematol Oncol       Date:  2015-11       Impact factor: 1.289

2.  Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups.

Authors:  Saskia M Maas; Fleur Vansenne; Daniel J M Kadouch; Abdulla Ibrahim; Jet Bliek; Saskia Hopman; Marcel M Mannens; Johannes H M Merks; Eamonn R Maher; Raoul C Hennekam
Journal:  Am J Med Genet A       Date:  2016-07-15       Impact factor: 2.802

Review 3.  Wilms' tumor. Overview of National Wilms' Tumor Study Group results.

Authors:  H L Neville; M L Ritchey
Journal:  Urol Clin North Am       Date:  2000-08       Impact factor: 2.241

4.  Is Nephron Sparing Surgery Justified in Wilms Tumor With Beckwith-Wiedemann Syndrome or Isolated Hemihypertrophy?

Authors:  Aurélien Scalabre; Christophe Bergeron; Frederic Brioude; Linda Dainese; Claire Cropet; Aurore Coulomb L'hermine; Claudia Pasqualini; Frederic Auber; Arnauld Verschuur; Gudrun Schleiermacher; Yves Le Bouc; Georges Audry; Sabine Irtan
Journal:  Pediatr Blood Cancer       Date:  2016-05-27       Impact factor: 3.167

5.  Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol.

Authors:  Alessandro Mussa; Cristina Molinatto; Giuseppina Baldassarre; Evelise Riberi; Silvia Russo; Lidia Larizza; Andrea Riccio; Giovanni Battista Ferrero
Journal:  J Pediatr       Date:  2016-06-29       Impact factor: 4.406

Review 6.  Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma.

Authors:  Jennifer M Kalish; Leslie Doros; Lee J Helman; Raoul C Hennekam; Roland P Kuiper; Saskia M Maas; Eamonn R Maher; Kim E Nichols; Sharon E Plon; Christopher C Porter; Surya Rednam; Kris Ann P Schultz; Lisa J States; Gail E Tomlinson; Kristin Zelley; Todd E Druley
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

7.  Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.

Authors:  Flavia Cerrato; Angela Sparago; Gaetano Verde; Agostina De Crescenzo; Valentina Citro; Maria Vittoria Cubellis; Maria Michela Rinaldi; Luigi Boccuto; Giovanni Neri; Cinzia Magnani; Paolo D'Angelo; Paola Collini; Daniela Perotti; Gianfranco Sebastio; Eamonn R Maher; Andrea Riccio
Journal:  Hum Mol Genet       Date:  2008-02-01       Impact factor: 6.150

Review 8.  Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.

Authors:  Frédéric Brioude; Jennifer M Kalish; Alessandro Mussa; Alison C Foster; Jet Bliek; Giovanni Battista Ferrero; Susanne E Boonen; Trevor Cole; Robert Baker; Monica Bertoletti; Guido Cocchi; Carole Coze; Maurizio De Pellegrin; Khalid Hussain; Abdulla Ibrahim; Mark D Kilby; Malgorzata Krajewska-Walasek; Christian P Kratz; Edmund J Ladusans; Pablo Lapunzina; Yves Le Bouc; Saskia M Maas; Fiona Macdonald; Katrin Õunap; Licia Peruzzi; Sylvie Rossignol; Silvia Russo; Caroleen Shipster; Agata Skórka; Katrina Tatton-Brown; Jair Tenorio; Chiara Tortora; Karen Grønskov; Irène Netchine; Raoul C Hennekam; Dirk Prawitt; Zeynep Tümer; Thomas Eggermann; Deborah J G Mackay; Andrea Riccio; Eamonn R Maher
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

9.  Isolated hemihyperplasia in an infant: an overlooked sign for wilms tumor development.

Authors:  Kamer Mutafoglu; Emre Cecen; Handan Cakmakci
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

10.  Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjects.

Authors:  Abdulla Ibrahim; Gail Kirby; Carol Hardy; Renuka P Dias; Louise Tee; Derek Lim; Jonathan Berg; Fiona MacDonald; Peter Nightingale; Eamonn R Maher
Journal:  Clin Epigenetics       Date:  2014-06-04       Impact factor: 6.551

View more
  9 in total

1.  Beckwith-Wiedemann syndrome in diverse populations.

Authors:  Kelly A Duffy; Brian J Sajorda; Alice C Yu; Evan R Hathaway; Katheryn L Grand; Matthew A Deardorff; Jennifer M Kalish
Journal:  Am J Med Genet A       Date:  2019-02-04       Impact factor: 2.802

2.  Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management.

Authors:  Kelly A Duffy; Christopher M Cielo; Jennifer L Cohen; Christina X Gonzalez-Gandolfi; Jessica R Griff; Evan R Hathaway; Jonida Kupa; Jesse A Taylor; Kathleen H Wang; Arupa Ganguly; Matthew A Deardorff; Jennifer M Kalish
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-08-30       Impact factor: 3.908

Review 3.  [Tumor predisposition syndromes and nephroblastoma : Early diagnosis with imaging].

Authors:  N Welter; R Furtwängler; G Schneider; N Graf; J-P Schenk
Journal:  Radiologie (Heidelb)       Date:  2022-08-25

4.  The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum.

Authors:  Alessandro Mussa; Kelly A Duffy; Diana Carli; Jessica R Griff; Riccardo Fagiano; Jonida Kupa; Garrett M Brodeur; Giovanni Battista Ferrero; Jennifer M Kalish
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-04       Impact factor: 4.553

5.  11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.

Authors:  Elise M Fiala; Michael V Ortiz; Jennifer A Kennedy; Dominik Glodzik; Megan Harlan Fleischut; Kelly A Duffy; Evan R Hathaway; Todd Heaton; Justin T Gerstle; Peter Steinherz; Neerav Shukla; Nicole McNeer; Kaitlyn Tkachuk; Nancy Bouvier; Karen Cadoo; Maria I Carlo; Alicia Latham; Marianne Dubard Gault; Vijai Joseph; Yelena Kemel; Alex Kentsis; Zsofia Stadler; Michael La Quaglia; Elli Papaemmanuil; Danielle Friedman; Arupa Ganguly; Andrew Kung; Kenneth Offit; Jennifer M Kalish; Michael F Walsh
Journal:  Cancer       Date:  2020-04-22       Impact factor: 6.860

6.  Characteristics Associated with Tumor Development in Individuals Diagnosed with Beckwith-Wiedemann Spectrum: Novel Tumor-(epi)Genotype-Phenotype Associations in the BWSp Population.

Authors:  Kelly A Duffy; Kelly D Getz; Evan R Hathaway; Mallory E Byrne; Suzanne P MacFarland; Jennifer M Kalish
Journal:  Genes (Basel)       Date:  2021-11-21       Impact factor: 4.096

7.  Improved molecular detection of mosaicism in Beckwith-Wiedemann Syndrome.

Authors:  Samuel W Baker; Kelly A Duffy; Jennifer Richards-Yutz; Matthew A Deardorff; Jennifer M Kalish; Arupa Ganguly
Journal:  J Med Genet       Date:  2020-05-19       Impact factor: 6.318

8.  Epigenetic mosaicism and cell burden in Beckwith-Wiedemann syndrome due to loss of methylation at imprinting control region 2.

Authors:  Kelly A Duffy; Evan R Hathaway; Steven D Klein; Arupa Ganguly; Jennifer M Kalish
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-12-09

Review 9.  Lateralized and Segmental Overgrowth in Children.

Authors:  Alessandro Mussa; Diana Carli; Simona Cardaropoli; Giovanni Battista Ferrero; Nicoletta Resta
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.